Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Lymphocytic, Chronic, B-Cell 3Lymphoma, Follicular 2Lymphoma 2Weight Loss 1Waldenstrom Macroglobulinemia 1Thrombocytopenia 1Splenomegaly 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphocytosis 1Lymphadenopathy 1Lung Neoplasms 1Kidney Neoplasms 1Insulin Resistance 1Immunoblastic Lymphadenopathy 1Hyperglycemia 1Hodgkin Disease 1

Interventions

liposomal amphotericin B 2Caspofungin 2ofatumumab 1Vancomycin 1Tazobactam 1Surveys and Questionnaires 1Ritonavir 1Quality of Life 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Moxifloxacin 1Metformin 1Mannose-Binding Lectin 1Levofloxacin 1Lenalidomide 1Ciprofloxacin 1Cefepime 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fever × Metformin × Lymphoid × Clear all
NCT02948283 2021-02-12

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

City of Hope Medical Center

Phase 1 Completed
3 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Lymphadenopathy, Anemia, Fatigue, Fever, Lymphocytosis, Multiple Myeloma, Splenomegaly, Thrombocytopenia, Weight Loss, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡